{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:28:04Z","timestamp":1761974884043},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1994,3,1]],"date-time":"1994-03-01T00:00:00Z","timestamp":762480000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[1994,3]]},"DOI":"10.1007\/bf01541341","type":"journal-article","created":{"date-parts":[[2005,4,19]],"date-time":"2005-04-19T19:24:08Z","timestamp":1113938648000},"page":"90-97","source":"Crossref","is-referenced-by-count":64,"title":["Bioavailability of ?-globulin after subcutaneous infusions in patients with common variable immunodeficiency"],"prefix":"10.1007","volume":"14","author":[{"given":"J.","family":"Waniewski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gardulf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Hammarstr\ufffdm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","volume-title":"Clinical Use of Intravenous Immunoglobulins","author":"HD Ochs","year":"1986","unstructured":"Ochs HD, Morell A, Skvaril F, Fischer SH, Wedgwood RJ: Survival of IgG subclasses following administration of intravenous gammaglobulin in patients with primary immunodeficiency diseases.In Clinical Use of Intravenous Immunoglobulins, A Morell, UE Nydegerr (eds). Academic Press, London 1986"},{"key":"CR2","first-page":"634","volume":"112","author":"S Mankarious","year":"1988","unstructured":"Mankarious S, Lee M, Fischer S, Pyun KH, Ochs HD, Oxelius VA, Wedgwood RJ: The half-lives of IgG subclasses and specific antibodies in patients with primary immunodeficiency who are receiving intravenously administered immunoglobulin. J Lab Clin Method 112:634?640, 1988","journal-title":"J Lab Clin Method"},{"key":"CR3","first-page":"225","volume":"23","author":"SH Fischer","year":"1988","unstructured":"Fischer SH, Ochs HD, Wedgwood RJ, Skvaril F, Morell A, Hill HR, Schiffmann G, Corey M: Survival of antigenspecific antibody following administration of intravenous immunoglobulin in patients with primary immunodeficiency diseases. Monogr Allergy 23:225?235, 1988","journal-title":"Monogr Allergy"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/08820139109050787","volume":"20","author":"ML Lee","year":"1991","unstructured":"Lee ML, Mankarious S, Ochs H, Fischer S, Wedgwood RJ: The pharmacokinetics of total IgG, IgG subclasses, and type specific antibodies in immunodeficient patients. Immunol Invest 20:193?198, 1991","journal-title":"Immunol Invest"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/B978-0-12-370725-3.50008-7","volume-title":"Immunotherapy with Intravenous Immunoglobulin","author":"RJ Wedgwood","year":"1991","unstructured":"Wedgwood RJ: The distribution and catabolism of IVIG preparations in immunodeficient patients.In Immunotherapy with Intravenous Immunoglobulin. London, Academic Press, 1991, pp 37?45"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF00918268","volume":"12","author":"HM Chapel","year":"1992","unstructured":"Chapel HM, Lee M: Immunoglobulin replacement in patients with chronic lymphocytic leukemia (CLL): Kinetics of immunoglobulin metabolism. J Clin Immunol 12:17?20, 1992","journal-title":"J Clin Immunol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(72)90926-9","volume":"1","author":"GN Smith","year":"1972","unstructured":"Smith GN, Griffiths B, Mollison D, Mollison PL: Uptake of IgG after intramuscular and subcutaneous injection. Lancet 1:1208?1212, 1972","journal-title":"Lancet"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0140-6736(91)90147-H","volume":"338","author":"A Gardulf","year":"1991","unstructured":"Gardulf A, Hammarstr\u00f6m L, Smith CIE: Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion. Lancet 338:162?166, 1991","journal-title":"Lancet"},{"key":"CR9","first-page":"195","volume":"3","author":"FS Rosen","year":"1992","unstructured":"Rosen FS, Wedgwood RJ, Eibl M, Griscelli C, Seligmann M, Aiuti F, Kishimoto T, Matsumoto S, Khakhalin LN, Hanson L\u00c5, Hitzig WH, Thompson RA, Cooper MD, Good RA, Waldmann TA. Primary immunodeficiency diseases. Report of a WHO scientific group. Immunodefic Rev 3:195, 1992","journal-title":"Immunodefic Rev"},{"key":"CR10","first-page":"1","volume":"13","author":"TA Waldmann","year":"1969","unstructured":"Waldmann TA, Strober W: Metabolism of immunoglobulins. Progr Allergy 13:1?110, 1969","journal-title":"Progr Allergy"},{"key":"CR11","volume-title":"Clinical Hematology","year":"1981","unstructured":"Wintrobe MM, Lee GR, Boggs DR, Bithell TC, Foerster J, Athens JW, Lukens JN (eds): Clinical Hematology. Philadelphia, Lee and Fabiger, 1981"},{"key":"CR12","first-page":"113","volume-title":"Immunotherapy. A Guide to Immunoglobulin Prophylaxis and Therapy","author":"F Skvaril","year":"1981","unstructured":"Skvaril F: Qualitative and quantitative aspects of IgG subclasses in I.V. immunoglobulin preparations.In Immunotherapy. A Guide to Immunoglobulin Prophylaxis and Therapy, UE Nydegger (ed). London, Academic Press, 1981, pp 113?122"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1172\/JCI106279","volume":"49","author":"A Morell","year":"1970","unstructured":"Morell A, Terry WD, Waldmann TA: Metabolic properties of IgG subclasses in man. J Clin Invest 49:673?680, 1970","journal-title":"J Clin Invest"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2249.1993.tb03380.x","volume":"92","author":"A Gardulf","year":"1993","unstructured":"Gardulf A, Bj\u00f6rell H, Gustafson R, Hammarstr\u00f6m L, Smith CIE. The life situations of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusions. Clin Exp Immunol 92:200?204, 1993","journal-title":"Clin Exp Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01541341.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01541341\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01541341","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T13:11:59Z","timestamp":1556889119000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01541341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,3]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1994,3]]}},"alternative-id":["BF01541341"],"URL":"https:\/\/doi.org\/10.1007\/bf01541341","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,3]]}}}